Yves Collette
Papers
1
Total Citations
72
H-Index
1
About
Yves Collette is a leading figure in drug discovery, with a research focus that bridges chemical biology and medicinal chemistry to streamline the hit-to-lead optimization process. His most cited work, the 2018 paper on the “Diversity-Oriented-Target-Focused-Synthesis” (DOTFS) approach, has garnered 72 citations and represents a major contribution to the field. In this study, Collette and his team tackled one of the most persistent bottlenecks in drug development: the automation of hit-to-lead optimization. By integrating fragment growing with a diversity-oriented synthesis strategy, they developed a time- and cost-efficient framework that allows researchers to rapidly evolve initial hits into potent lead compounds. This work has had a tangible impact, providing a practical blueprint for accelerating early-stage drug discovery. Beyond this flagship publication, Collette’s broader contributions continue to influence how chemists design and refine compound libraries, making him a respected voice in the community. His achievements underscore a commitment to solving real-world challenges in pharmaceutical research, offering students and researchers a model for combining rigorous chemical synthesis with strategic target focus.
Research Focus
Key Achievements
Top Papers
- 1